TRACON PHARMACEUTICALS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TCON and buy or sell other stocks, ETFs, and their options commission-free!

About TCON

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. 

CEO
Charles P. Theuer
CEOCharles P. Theuer
Employees
26
Employees26
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2004
Founded2004
Employees
26
Employees26

TCON Key Statistics

Market cap
963.99K
Market cap963.99K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
262.47K
Average volume262.47K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.73
52 Week high$1.73
52 Week low
$0.2781
52 Week low$0.2781
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.